Product Overview
Generic Name: Oxycodone hydrochloride[citation:3]
Brand Name: Roxicodone®[citation:3][citation:8]
Manufacturer: SpecGx LLC (Mallinckrodt)[citation:8]
DEA Schedule: CII (Schedule II Controlled Substance)[citation:8]
Imprint Code: RP20
Strength: 20mg immediate-release tablet[citation:3][citation:10]
Initial FDA Approval: 1950[citation:8]
Roxicodone is an immediate-release formulation of oxycodone hydrochloride, a semi-synthetic opioid agonist derived from thebaine (an alkaloid found in the opium poppy). Unlike extended-release formulations (such as OxyContin or Xtampza ER), the immediate-release tablet provides rapid onset of analgesia and is typically dosed every 4-6 hours as needed for pain[citation:3][citation:8].
Imprint Code Information (RP20)
| Property | Information |
|---|---|
| Imprint Code | RP20 |
| Strength | 20 mg |
| Dosage Form | Immediate-release tablet |
| Manufacturer | SpecGx LLC (Mallinckrodt)[citation:8] |
Indications and Usage
Roxicodone is indicated for the management of pain severe enough to require opioid treatment and for which alternative treatment options (non-opioid analgesics or opioid combination products) are inadequate[citation:1][citation:8].
Important limitations:
- Immediate-release formulation is typically used for acute pain or breakthrough pain[citation:3]
- Should be taken at the lowest effective dose for the shortest possible duration[citation:1][citation:8]
- Roxicodone is NOT indicated for as-needed (prn) use without a prescription[citation:8]
Available Strengths (Immediate-Release Tablets)
Roxicodone immediate-release tablets are available in the following strengths[citation:3][citation:10]:
- 5 mg
- 10 mg
- 15 mg
- 20 mg (RP20)
- 30 mg
Dosage and Administration
Typical Dosing for Opioid-Naïve Patients:
- Starting dose: 5-15 mg every 4-6 hours as needed for pain[citation:4]
- Individualize dosing based on pain severity and patient response
- Use the lowest effective dose for the shortest duration[citation:1][citation:8]
Important Administration Instructions[citation:3][citation:8]:
- Take exactly as prescribed — do not change your dose
- Take every 4-6 hours as needed for pain
- If you miss a dose, take your next dose at the usual time (do not double up)
- Take with or without food — if nausea occurs, taking with food may help[citation:1]
- For acute (short-term) pain, you may only need to take Roxicodone for a few days[citation:3][citation:8]
Grapefruit Interaction Warning: Avoid eating grapefruit or drinking grapefruit juice while taking Roxicodone unless approved by your healthcare provider, as grapefruit can increase the chance of side effects[citation:1].
Mechanism of Action
Oxycodone is a full opioid agonist with relative selectivity for the mu-opioid receptor (MOR). By binding to and activating mu-opioid receptors in the central nervous system (CNS), oxycodone[citation:5]:
- Inhibits ascending pain pathways
- Alters pain perception in the brain
- Produces analgesia, sedation, and euphoria
- Has no ceiling effect for analgesia — higher doses produce increasing pain relief but also increasing risk of respiratory depression and death
Pharmacokinetics
| Parameter | Information |
|---|---|
| Onset of action (immediate-release) | 10-30 minutes |
| Peak effect | 1-2 hours |
| Duration of action (immediate-release) | 3-6 hours |
| Bioavailability (oral) | 60-87% (high) |
| Elimination half-life | 3-5 hours |
BOXED WARNINGS (FDA)
The following boxed warnings apply to Roxicodone (oxycodone)[citation:8]:
- Addiction, Abuse, and Misuse: Oxycodone exposes users to risks of addiction, abuse, and overdose even at recommended doses. Misuse can lead to overdose and death[citation:1][citation:8].
- Life-Threatening Respiratory Depression: Serious, fatal respiratory depression can occur. Risk is highest during initiation and dose titration[citation:1][citation:5].
- Accidental Ingestion: Accidental ingestion of even one dose, especially in children, can be fatal[citation:1][citation:8].
- Neonatal Opioid Withdrawal Syndrome (NOWS): Prolonged use during pregnancy can result in life-threatening withdrawal in newborns[citation:8].
- Risks from Concomitant Use with Benzodiazepines, Gabapentinoids, or Other CNS Depressants: Concomitant use with benzodiazepines, gabapentin (Neurontin), pregabalin (Lyrica), alcohol, or other CNS depressants can cause profound sedation, respiratory depression, coma, and death[citation:8].
Contraindications
Roxicodone is contraindicated in patients with[citation:8]:
- Severe asthma, trouble breathing, or other lung problems[citation:8]
- Bowel blockage or narrowing of the stomach or intestines[citation:8]
- Known hypersensitivity to oxycodone or any component of the formulation[citation:8]
Additional contraindications based on clinical guidelines:
- Concurrent use of monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI discontinuation
- Paralytic ileus
Warnings and Precautions
| Warning/Precaution | Clinical Consideration |
|---|---|
| Respiratory Depression | Chief hazard of opioid agonists. Occurs most frequently in elderly or debilitated patients, following large initial doses in non-tolerant patients, or when given with other CNS depressants[citation:5] |
| COPD and Respiratory Conditions | Use with extreme caution in patients with COPD, cor pulmonale, or decreased respiratory reserve[citation:5] |
| Hypotensive Effect | May cause severe hypotension in hypovolemic patients or after concurrent administration with phenothiazines[citation:5] |
| Adrenal Insufficiency | Prolonged use may cause secondary adrenal insufficiency[citation:1] |
| Sleep Apnea | Opioids can cause central sleep apnea and worsen existing sleep-disordered breathing[citation:1] |
| Constipation | Opioids decrease propulsive peristaltic waves in the colon, leading to constipation[citation:5] |
Adverse Reactions (Side Effects)
Most Common (≥5% and greater than placebo)[citation:1][citation:5]:
- Nausea and vomiting
- Constipation (very common — may require prophylactic laxatives)
- Lightheadedness, dizziness
- Drowsiness (somnolence)
- Headache
- Pruritus (itching)
- Dry mouth
- Sweating
- Weakness, fatigue
Serious Adverse Reactions (Seek immediate medical attention)[citation:1][citation:5]:
- Respiratory depression: Slow/shallow breathing, difficulty breathing, apnea
- Severe hypotension: Fainting, lightheadedness
- Seizures
- Serotonin syndrome: Agitation, confusion, muscle rigidity, hyperthermia (when combined with serotonergic drugs)
- Sleep apnea: Interrupted breathing during sleep[citation:1]
- Adrenal insufficiency: Loss of appetite, unusual tiredness, weight loss[citation:1]
- Severe allergic reaction: Rash, itching/swelling (especially of face/tongue/throat), severe dizziness, trouble breathing[citation:1]
Gastrointestinal Effects (Mechanism-Based)
Oxycodone produces opioid-related effects on the gastrointestinal tract[citation:5]:
- Nausea and vomiting caused by direct stimulation of the chemoreceptor trigger zone (CTZ) in the medulla — frequency and severity diminish with time
- Decreased gastric motility and increased tone of the antrum, stomach, and duodenum
- Delayed digestion and decreased propulsive contractions in the small intestine
- Decreased propulsive peristaltic waves in the colon, increased tone to the point of spasm — resulting in constipation
- Possible spasm of sphincter of Oddi and transient elevations in serum amylase
Cardiovascular Effects
At therapeutic doses, oxycodone produces[citation:5]:
- Peripheral vasodilatation (arteriolar and venous)
- Decreased peripheral resistance
- Inhibition of baroreceptor reflexes
- Orthostatic hypotension (especially in ambulatory patients)
- Manifestations of histamine release: pruritus, flushing, red eyes, sweating, orthostatic hypotension
Caution is required in hypovolemic patients (e.g., acute myocardial infarction) as opioids may cause or aggravate hypotension[citation:5].
Tolerance and Dependence
- Tolerance: Higher doses required over time to achieve same analgesic effect
- Physical dependence: Abrupt discontinuation causes withdrawal syndrome. Babies born to mothers who use opioids long-term may develop severe (possibly fatal) withdrawal symptoms[citation:1]
- Addiction (Opioid Use Disorder): Characterized by compulsive use, loss of control, and continued use despite harm
Withdrawal Symptoms: These include[citation:1]:
- Agitation, anxiety, insomnia
- Yawning, tearing, runny nose
- Sweating, chills, goosebumps
- Muscle aches, bone pain
- Nausea, vomiting, diarrhea
- Dilated pupils, tachycardia, hypertension
- In newborns: Crying that does not stop, slow/shallow breathing, irritability, shaking, vomiting, diarrhea, poor feeding, difficulty gaining weight[citation:1]
Overdose Signs and Treatment
Overdose Signs[citation:1]:
- Pinpoint pupils (miosis)
- Respiratory depression (slow, shallow, or stopped breathing)
- Extreme somnolence or unresponsiveness — difficulty waking up
- Cold, clammy skin
- Bradycardia, hypotension
- Coma
Overdose Treatment (Emergency)[citation:1][citation:8]:
- Naloxone (Narcan) or nalmefene: Opioid antagonists — multiple doses may be required due to oxycodone’s duration of action
- Call 911 or local emergency services immediately
- Rescue breathing and CPR as needed
- Supportive care (airway management, oxygen, IV fluids)
- Ask your healthcare provider about having naloxone available to treat opioid overdose[citation:8]
Drug Interactions
| Drug Class | Interaction | Risk Level |
|---|---|---|
| Benzodiazepines | Additive CNS depression, increased overdose risk[citation:8] | High |
| Gabapentinoids (gabapentin, pregabalin) | Increased sedation and respiratory depression[citation:8] | High |
| Alcohol | Profound sedation, respiratory depression, death[citation:1][citation:8] | High |
| Other opioids | Additive effects, overdose risk | High |
| MAO inhibitors | Potentially fatal reaction | Life-threatening |
| Serotonergic drugs (SSRIs, SNRIs, triptans) | Serotonin syndrome risk | Moderate to High |
| CYP3A4 inhibitors (grapefruit juice, erythromycin, ketoconazole) | Increased oxycodone levels, increased toxicity[citation:1] | Moderate to High |
Use in Specific Populations
| Population | Consideration |
|---|---|
| Pregnancy | May slightly increase risk of birth defects if used during first two months. Prolonged use near delivery may cause neonatal withdrawal syndrome (NOWS)[citation:1][citation:8]. |
| Breastfeeding | Oxycodone passes into breast milk — discuss risks and benefits with healthcare provider |
| Geriatric (≥65 years) | Increased sensitivity to side effects (dizziness, sedation, constipation, respiratory depression). Lower starting doses recommended[citation:5] |
| Renal impairment | Dose adjustment recommended — use lower starting doses |
| Hepatic impairment | Significant dose reduction required (33-50% of usual dose) — monitor carefully[citation:6] |
| Pediatric | Safety and efficacy not established in pediatric patients |
Storage and Disposal
- Storage: Store securely in a locked cabinet out of sight and reach of children, and in a location not accessible by others (including visitors to the home)[citation:1][citation:8]. Store between 59°F and 86°F (15°C-30°C)[citation:4].
- Disposal: The FDA recommends flushing unused oxycodone down the toilet when it is no longer needed if a drug take-back option is not readily available (immediate risk from accidental exposure)[citation:7][citation:8]. Alternatively, use authorized DEA drug take-back program or DEA-registered collector.
Never give your Roxicodone to anyone else — they could die from taking it. Selling or giving away Roxicodone is against the law[citation:8].
Product Identification Summary
| Property | Description |
|---|---|
| Imprint Code | RP20 |
| Strength | 20 mg |
| Dosage Form | Immediate-release tablet |
| Brand Name | Roxicodone |
| Generic Name | Oxycodone hydrochloride |
| Manufacturer | SpecGx LLC (Mallinckrodt)[citation:8] |
Legal Status (United States)
Roxicodone (oxycodone) is a Schedule II (CII) controlled substance under the Controlled Substances Act[citation:8]. Key restrictions:
- Prescription required — no refills permitted without a new prescription[citation:8]
- DEA registration required for prescribing and dispensing
- Records must be maintained separately from non-controlled prescriptions
- Illegal to possess without a valid prescription
- Penalties for illegal possession: up to 1 year imprisonment + fines (first offense)
- Selling or giving away Roxicodone is against the law and can result in criminal prosecution[citation:8]
Diversion and Counterfeit Warning (Educational)
Oxycodone (Roxicodone, OxyContin) has been subject to significant diversion and abuse. Counterfeit tablets, including those imprinted with “RP20,” have been found in the illicit market containing fentanyl or other dangerous adulterants. Patients should only obtain Roxicodone from licensed pharmacies with a valid prescription.
Educational Summary
Roxicodone 20mg (RP20) is an immediate-release oxycodone tablet indicated for moderate to severe pain. It is a Schedule II controlled substance with multiple boxed warnings for addiction, respiratory depression, and fatal interactions with CNS depressants. The medication should be taken exactly as prescribed at the lowest effective dose for the shortest duration. Roxicodone is for opioid-naïve and opioid-tolerant patients but requires careful dosing and monitoring. Naloxone should be available for overdose reversal. Store securely, dispose of unused medication via flushing or take-back programs, and never share with others. Illegal possession is a criminal offense[citation:8].
Note: This information is for educational and awareness purposes only. Roxicodone (oxycodone) is a Schedule II controlled substance with high potential for abuse, addiction, overdose, and death. It is illegal to possess, sell, or distribute without a valid prescription. Nothing here is medical advice or an endorsement of use. If you or someone you know is experiencing a medical emergency, call 911 immediately. If you need help for substance use, contact SAMHSA at 1-800-662-4357.



